• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Mast Therapeutics, Inc. (MSTX)

    -NYSE MKT
    0.44 Up 0.01(1.51%) 4:01PM EST
    Add to Portfolio
    Prev Close:0.43
    Open:0.43
    Bid:0.00 x 999900
    Ask:0.65 x 700
    1y Target Est:2.38
    Beta:0.42
    Next Earnings Date:N/A
    Day's Range:0.43 - 0.45
    52wk Range:0.40 - 0.93
    Volume:411,725
    Avg Vol (3m):1,053,890
    Market Cap:56.16M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MSTX

    Comparison

    Symbol% ChgMkt Cap
    MSTXUp 1.51%56.16M
    GSKDown 2.57%105.78B
    RHHBYDown 1.79%N/A
    SNYDown 1.94%120.95B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.06
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mast Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases. It primarily develops MST-188, a phase III product candidate that has hemorheologic, cytoprotective, and anti-inflammat... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback